267 related articles for article (PubMed ID: 3480668)
1. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
Staab HJ
Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
Heptner G; Domschke S; Domschke W
Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
[No Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation.
Denk H; Tappeiner G; Eckerstorfer R; Holzner JH
Int J Cancer; 1972 Sep; 10(2):262-72. PubMed ID: 4350187
[No Abstract] [Full Text] [Related]
7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
[TBL] [Abstract][Full Text] [Related]
9. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
10. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
[TBL] [Abstract][Full Text] [Related]
11. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
12. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
13. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
[No Abstract] [Full Text] [Related]
14. Clinical significance of serum CA125 values in patients with cancers of the digestive system.
Haga Y; Sakamoto K; Egami H; Yoshimura R; Mori K; Akagi M
Am J Med Sci; 1986 Jul; 292(1):30-4. PubMed ID: 3459357
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Kuusela P; Haglund C; Roberts PJ; Jalanko H
Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract.
Holyoke D; Reynoso G; Chu TM
Ann Surg; 1972 Oct; 176(4):559-64. PubMed ID: 5077412
[No Abstract] [Full Text] [Related]
17. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
18. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
[No Abstract] [Full Text] [Related]
20. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
[Next] [New Search]